🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
1.950
-0.180 (-8.45%)
Nov 20, 2026, 4:00 PM EST - Market closed

AC Immune Income Statement

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
19.813.5727.3114.83.94-
Revenue Growth
353.20%-86.92%84.51%276.14%-74.50%-
Cost of Revenue
42.756.4462.5754.6160.3462.28
Gross Profit
-22.88-52.86-35.26-39.81-56.4-62.28
Selling, General & Admin
15.4316.0917.2615.3115.7917.91
Other Operating Expenses
-0.51-0.09-0.14-1.49-1.34-1.18
Operating Expenses
14.921617.1213.8214.4516.73
Operating Income
-37.8-68.86-52.38-53.62-70.85-79.01
Interest Expense
-0.23-0.19-0.13-0.18-0.36-0.58
Interest & Investment Income
1.031.873.21.040.076.49
Currency Exchange Gain (Loss)
0.94-2.8-1.6-1.470.390.11
EBT Excluding Unusual Items
-36.06-69.99-50.91-54.22-70.74-72.99
Merger & Restructuring Charges
0.01-0.46----
Pretax Income
-36.05-70.45-50.91-54.22-70.74-72.99
Income Tax Expense
--00.010.010
Net Income
-36.05-70.45-50.92-54.23-70.75-73
Net Income to Common
-36.05-70.45-50.92-54.23-70.75-73
Net Income Growth
------
Shares Outstanding (Basic)
103101100858475
Shares Outstanding (Diluted)
103101100858475
Shares Change
2.58%1.06%17.71%1.36%11.48%4.24%
EPS (Basic)
-0.35-0.70-0.51-0.64-0.85-0.97
EPS (Diluted)
-0.35-0.70-0.51-0.64-0.85-0.97
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
--70.1665.27-61.21-74.81-68.32
Free Cash Flow Per Share
--0.700.66-0.72-0.90-0.91
Gross Margin
-115.49%--129.12%-268.94%--
Operating Margin
-190.79%-1927.32%-191.80%-362.30%-1800.43%-
Profit Margin
-181.95%-1971.65%-186.44%-366.41%-1798.04%-
Free Cash Flow Margin
--1963.67%238.99%-413.55%-1901.07%-
EBITDA
-36.43-67.47-50.89-51.95-69.05-77.11
EBITDA Margin
-183.86%--186.36%---
D&A For EBITDA
1.371.391.491.671.791.9
EBIT
-37.8-68.86-52.38-53.62-70.85-79.01
EBIT Margin
-190.79%--191.80%---
Revenue as Reported
19.813.5727.3114.83.94-
SEC Filings: 10-K · 10-Q